Inventor
AFTAB DANA T
US18 patents
⚠️ This page may combine multiple inventors who share the name “AFTAB DANA T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXELIXIS INC
15 patentsUS9861624B2Jan 9, 2018
Method of treating cancer
EXELIXIS INC24 citations93
US10501418B2Dec 10, 2019
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC12 citations91
US10166225B2Jan 1, 2019
Method for treating osteoporosis
EXELIXIS INC23 citations91
US11724986B2Aug 15, 2023
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC6 citations84
US10273211B2Apr 30, 2019
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
EXELIXIS INC17 citations84
US10159666B2Dec 25, 2018
Dosing of cabozantinib formulations
EXELIXIS INC21 citations84
US11433064B2Sep 6, 2022
Methods of using c-Met modulators
EXELIXIS INC6 citations82
US10851061B2Dec 1, 2020
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC8 citations82
US10736886B2Aug 11, 2020
Methods of using c-Met modulators
EXELIXIS INC11 citations82
US11141413B2Oct 12, 2021
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
EXELIXIS INC8 citations77
US11065240B2Jul 20, 2021
Drug combinations to treat multiple myeloma
EXELIXIS INC6 citations72
US11760726B2Sep 19, 2023
Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC2 citations71
US12486233B2Dec 2, 2025
Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC0 citations61
US11504363B2Nov 22, 2022
Method of treating cancer and bone cancer pain
EXELIXIS INC0 citations60
US11116759B2Sep 14, 2021
Method of treating cancer
EXELIXIS INC0 citations53
AFTAB DANA T
3 patentsUS8642584B2Feb 4, 2014
Method of using PI3K and MEK modulators
AFTAB DANA T22 citations85
US9011863B2Apr 21, 2015
Combinations of kinase inhibitors for the treatment of cancer
AFTAB DANA T9 citations75
US8901137B2Dec 2, 2014
Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors
AFTAB DANA T4 citations60